Indeed, in 2003 Abifadel et al., studying gene mutations responsible for familial hypercholesterolemia (FH), found that mutations in the PCSK9 gene cause dominant hypercholesterolemia in pedigree analysis. Here, PCSK9 is linked to familial hyperaldosteronism.